After a tension-packed two days that saw recommended changes to the MMRV vaccine schedule and COVID-19 vaccine access, as ...
The House Committee on Energy and Commerce has cleared proposed legislation that could bring back the FDA’s rare pediatric ...
Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new ...
BMO Capital Markets analysts said the first day of the CDC vaccine advisory committee meeting Thursday had anti-vaccine ...
Nektar Therapeutics still needs to establish what differentiates rezpeg from other atopic dermatitis therapies, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback